1. Minamimoto R, Senda M, Uno K, Jinnouchi S, Iinuma T, Ito K, et al. Performance profile of FDG-PET and PET/CT for cancer screening on the basis of a Japanese nationwide survey. Ann Nucl Med. 2007;21:481–98.
2. Kawada S, Suzuki Y, Hinohara S, Koide S, Ono Y, Ashikaga H. Cancer screening with PET: advantages and limitations. Rinsho Byori. 2007;55:656–67. (abstract in English).
3. Yasuda S, Ide M. PET and cancer screening. Ann Nucl Med. 2005;19:167–77.
4. Sugihara S, Igarashi I, Takura T, Noguchi H, Ueno Y, Kawabuchi K. Asymmetric information and heterogeneous preferences in a health care market. In: Kawabuchi K, Igarashi I, Takura T, Sugihara S, Noguchi H, Ueno Y, et al, editors. Designing long-term and health care systems: menu of services, prices and competition: report article of ESRI International Collaboration Projects 2006: toward the sustainable growth and the financial reconstruction in the aging society. Tokyo: Economic and Social Research Institute (ESRI); 2007. p. 69–116. http://www.esri.go.jp/jp/workshop/070706/05_02.pdf (uploaded 2007 Jul 6; cited 2007 Jul 9).
5. Mitsutake N, Oku S, Fujii R, Furui Y, Yasunaga H. Business administration of PET facilities: a cost analysis of three facilities utilizing delivery FDG. Kaku Igaku (Jpn J Nucl Med). 2008;45:119–23. (abstract in English).